BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17922414)

  • 1. Analysis of SOX4 gene mutation in non-small cell lung cancer tissues.
    Chen QL; Zheng WL; Yao WJ; Nie LW; Cheng SH; Ma WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):505-9. PubMed ID: 17922414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
    Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
    Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
    Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma.
    Chen HL; Fan LF; Gao J; Ouyang JP; Zhang YX
    Oncol Rep; 2011 Feb; 25(2):359-66. PubMed ID: 21165568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
    Gao ZQ; Gao Z; Zhang X
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mutations in exon 19 of EGFR gene in non-small cell lung cancer from Chinese patients].
    Wang HY; Luo H; Zhao YM; Tang L; Zhou CC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):315-8. PubMed ID: 18543225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development and application of the method for controlling contamination of tumor samples with normal cells to detect deletion of P16 gene in primary lung carcinoma].
    Ran R; Cao XA; Tian Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):136-40. PubMed ID: 10072815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers.
    Lee SH; Shin MS; Kim HS; Lee HK; Park WS; Kim SY; Lee JH; Han SY; Park JY; Oh RR; Jang JJ; Han JY; Lee JY; Yoo NJ
    Cancer Res; 1999 Nov; 59(22):5683-6. PubMed ID: 10582684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
    Lou Y; Fang CQ; Li JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutations in non-small cell lung cancer from Thai patients.
    Petmitr S; Makthiengtrong S; Sutinont P; Migasena P
    J Med Assoc Thai; 1999 Mar; 82(3):250-5. PubMed ID: 10410479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53AIP1 expression can be a prognostic marker in non-small cell lung cancer.
    Yamashita SI; Masuda Y; Yoshida N; Matsuzaki H; Kurizaki T; Haga Y; Ikei S; Miyawaki M; Kawano Y; Chujyo M; Kawahara K
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):148-51. PubMed ID: 17851056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p16INK4/CDKN2 gene deletions and mutations in non-small cell lung cancers].
    Wang G; Du C; Lin Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Feb; 15(1):5-8. PubMed ID: 9456359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.